🇺🇸 FDA

Intelligence · Patent portfolio

IONIS PHARMACEUTICALS Patents

Full USPTO pharma patent portfolio for IONIS PHARMACEUTICALS — grant dates, expiration, and drug cross-links.

Patents
222
Expiring ≤24m
0

Quick answer

IONIS PHARMACEUTICALS has 222 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Page 4 of 5

  1. US 10415038

    Compounds and methods for modulating TMPRSS6 expression

    Expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10407680

    Compounds and methods for reducing Tau expression

    Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10407678

    Compositions for modulating expression of C9ORF72 antisense transcript

    Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10370659

    Compounds and methods for increasing antisense activity

    Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10308934

    Compositions for modulating Ataxin 2 expression

    Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10294477

    Compositions and methods for modulating PKK expression

    Expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10280423

    Compositions and methods for modulating complement factor B expression

    Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10266825

    Compositions comprising alternating 2′-modified nucleosides for use in gene modulation

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10260069

    Selective antisense compounds and uses thereof

    Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10221414

    Compositions for modulating C9ORF72 expression

    Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10202603

    Modulation of huntingtin expression

    Expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10184125

    Modulation of TMPRSS6 expression

    Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10174318

    Antisense oligonucleotide compositions

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10138482

    Compositions for modulating C9ORF72 expression

    Expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10100310

    Modulation of prekallikrein (PKK) expression

    Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10098959

    Method for synthesis of reactive conjugate clusters

    Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10087210

    Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom

    Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10036019

    Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom

    Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9994855

    Compositions and methods for modulating growth hormone receptor expression

    Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9976138

    Methods and compounds useful in conditions related to repeat expansion

    Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9957504

    Compositions and methods for modulating apolipoprotein (a) expression

    Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9957292

    Compositions and methods for modulating angiopoietin-like 3 expression

    Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9943539

    2′-methoxy substituted oligomeric compounds and compositions for use in gene modulations

    Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9943604

    Targeted therapeutic nucleosides and their use

    Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9943538

    2′-methoxy substituted oligomeric compounds and compositions for use in gene modulations

    Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9932581

    Compositions and methods for modulating apolipoprotein C-III expression

    Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9932580

    Compositions and methods for modulating HBV expression

    Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9920321

    Compositions and their uses directed to huntingtin

    Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9909124

    Compounds and methods for modulating apolipoprotein C-III expression for improving a diabetic profile

    Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9885045

    Methods and compositions for modulating apolipoprotein (a) expression

    Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9884072

    Methods and compositions for modulating apolipoprotein (a) expression

    Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9885047

    Modulation of TMPRSS6 expression

    Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9873876

    Cancer treatment

    Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9827263

    2′-methoxy substituted oligomeric compounds and compositions for use in gene modulations

    Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9816092

    Modulation of transthyretin expression

    Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9796976

    Methods and compositions for modulating alpha-1 antitrypsin expression

    Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9765338

    Modulation of dystrophia myotonica-protein kinase (DMPK) expression

    Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9725722

    Modulation of TMPRSS6 expression

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9714421

    Compositions and methods

    Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9708610

    Compositions comprising alternating 2′-modified nucleosides for use in gene modulation

    Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9695475

    Competitive modulation of microRNAs

    Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9688987

    Antisense oligonucleotides directed against connective tissue growth factor and uses thereof

    Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9683235

    Compositions for modulating Tau expression

    Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9683236

    Modulation of huntingtin expression

    Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9677076

    Modulation of hepatitis B virus (HBV) expression

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9670492

    Modulation of prekallikrein (PKK) expression

    Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9663783

    Modulation of alpha synuclein expression

    Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9650636

    Methods for treating hypercholesterolemia

    Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does IONIS PHARMACEUTICALS have?

222 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do IONIS PHARMACEUTICALS patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.